Top compounds associated with response to TBC1D14


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.19 0.0004
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.12 0.0004
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.17 0.0006
mRNA PD-0325901 CCLE pan-cancer AAC 0.15 0.0008
Download CSV